David Pubill

2.7k total citations
85 papers, 2.2k citations indexed

About

David Pubill is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Toxicology. According to data from OpenAlex, David Pubill has authored 85 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cellular and Molecular Neuroscience, 44 papers in Molecular Biology and 38 papers in Toxicology. Recurrent topics in David Pubill's work include Neurotransmitter Receptor Influence on Behavior (52 papers), Forensic Toxicology and Drug Analysis (38 papers) and Neuroscience and Neuropharmacology Research (28 papers). David Pubill is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (52 papers), Forensic Toxicology and Drug Analysis (38 papers) and Neuroscience and Neuropharmacology Research (28 papers). David Pubill collaborates with scholars based in Spain, Mexico and Austria. David Pubill's co-authors include Elena Escubedo, Jorge Camarasa, Raúl López‐Arnau, José Martínez-Clemente, Antoni Camins, Jordi Camarasa, Mercè Pallàs, Anna M. Canudas, Francesc X. Sureda and Andrés Jiménez and has published in prestigious journals such as PLoS ONE, Brain Research and International Journal of Molecular Sciences.

In The Last Decade

David Pubill

84 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Pubill Spain 28 1.4k 1.0k 754 608 323 85 2.2k
Elena Escubedo Spain 31 1.6k 1.1× 1.0k 1.0× 993 1.3× 609 1.0× 339 1.0× 114 2.7k
Jorge Camarasa Spain 24 1.1k 0.8× 818 0.8× 684 0.9× 499 0.8× 221 0.7× 80 2.1k
João Paulo Capela Portugal 22 775 0.5× 794 0.8× 297 0.4× 416 0.7× 412 1.3× 53 1.6k
M. Isabel Colado Spain 25 1.9k 1.3× 1.8k 1.8× 289 0.4× 1.2k 2.0× 1.0k 3.2× 34 2.9k
Norberto Aguirre Spain 25 759 0.5× 389 0.4× 666 0.9× 265 0.4× 385 1.2× 47 1.7k
Paul L. Prather United States 37 2.1k 1.5× 1.3k 1.3× 1.2k 1.6× 380 0.6× 2.1k 6.5× 96 3.8k
R.A. Rabin United States 21 1.2k 0.8× 115 0.1× 524 0.7× 586 1.0× 155 0.5× 51 1.5k
David B. Wainscott United States 24 1.0k 0.7× 83 0.1× 1.2k 1.5× 219 0.4× 338 1.0× 40 2.3k
Eileen M. Briley United States 14 1.3k 0.9× 280 0.3× 434 0.6× 67 0.1× 1.9k 5.8× 15 2.6k
Robert B. Laprairie Canada 24 1.2k 0.9× 173 0.2× 598 0.8× 145 0.2× 2.1k 6.4× 80 2.6k

Countries citing papers authored by David Pubill

Since Specialization
Citations

This map shows the geographic impact of David Pubill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pubill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pubill more than expected).

Fields of papers citing papers by David Pubill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Pubill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pubill. The network helps show where David Pubill may publish in the future.

Co-authorship network of co-authors of David Pubill

This figure shows the co-authorship network connecting the top 25 collaborators of David Pubill. A scholar is included among the top collaborators of David Pubill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Pubill. David Pubill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lardeux, Virginie, David Pubill, Ján Kehr, et al.. (2026). Neurochemical and behavioral evidence of high abuse liability of 3F-NEB, a novel synthetic cathinone. European Journal of Pharmacology. 1015. 178570–178570.
2.
Lardeux, Virginie, Stéphanie Pain, Fuhua Wang, et al.. (2025). Unveiling the potential abuse liability of α-D2PV: A novel α-carbon phenyl-substituted synthetic cathinone. Neuropharmacology. 272. 110425–110425. 2 indexed citations
3.
Pubill, David, et al.. (2024). Structure–Activity Relationship of Synthetic Cathinones: An Updated Review. ACS Pharmacology & Translational Science. 7(9). 2588–2603. 7 indexed citations
4.
Berzosa, Xavier, Roger Estrada‐Tejedor, Mohammad Nazmul Islam, et al.. (2024). Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties. Molecular Psychiatry. 29(8). 2346–2358. 3 indexed citations
5.
Gómez‐Canela, Cristian, David Pubill, Demetrio Raldúa, et al.. (2024). Acute Paraoxon-Induced Neurotoxicity in a Mouse Survival Model: Oxidative Stress, Dopaminergic System Alterations and Memory Deficits. International Journal of Molecular Sciences. 25(22). 12248–12248. 1 indexed citations
6.
Castro‐Zavala, Adriana, Marina D. Reguilón, Marina Bellot, et al.. (2024). Sex differences in the effects of N‐ethylpentylone in young CD1 mice: Insights on behaviour, thermoregulation and early gene expression. British Journal of Pharmacology. 181(22). 4491–4513. 1 indexed citations
7.
Teixidó, Elisabet, Demetrio Raldúa, David Pubill, et al.. (2023). First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation. International Journal of Molecular Sciences. 24(18). 13869–13869. 3 indexed citations
8.
Estrada‐Tejedor, Roger, Xavier Berzosa, Xavier Batllori, et al.. (2022). Neuropsychopharmacology of Emerging Drugs of Abuse: meta- and para-Halogen-Ring-Substituted α-PVP (“flakka”) Derivatives. International Journal of Molecular Sciences. 23(4). 2226–2226. 13 indexed citations
9.
Reguilón, Marina D., Marina Bellot, Xavier Berzosa, et al.. (2021). Behavioural and neurochemical effects after repeated administration of N‐ethylpentylone (ephylone) in mice. Journal of Neurochemistry. 160(2). 218–233. 6 indexed citations
10.
Abad, Sònia, Raúl López‐Arnau, Jaume Folch, et al.. (2019). Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice. Journal of Psychopharmacology. 33(9). 1170–1182. 8 indexed citations
11.
López‐Arnau, Raúl, et al.. (2019). 7,8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: Differential role of the BDNF-TrkB pathway. Biochemical Pharmacology. 163. 84–93. 9 indexed citations
12.
López‐Arnau, Raúl, et al.. (2018). Neuroadaptive changes and behavioral effects after a sensitization regime of MDPV. Neuropharmacology. 144. 271–281. 19 indexed citations
13.
López‐Arnau, Raúl, José Rodríguez-Morató, Jorge Camarasa, et al.. (2017). The combination of MDPV and ethanol results in decreased cathinone and increased alcohol levels. Study of such pharmacological interaction. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 76. 19–28. 8 indexed citations
14.
Abad, Sònia, Jorge Camarasa, David Pubill, Antoni Camins, & Elena Escubedo. (2015). Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits. Molecular Neurobiology. 53(10). 7271–7283. 20 indexed citations
15.
López‐Arnau, Raúl, et al.. (2015). Serotonin is involved in the psychostimulant and hypothermic effect of 4-methylamphetamine in rats. Neuroscience Letters. 590. 68–73. 3 indexed citations
16.
Abad, Sònia, Fèlix Junyent, Carme Auladell, et al.. (2014). 3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 54. 231–242. 9 indexed citations
17.
Camarasa, Jorge, et al.. (2014). Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in the rat brain: An autoradiography study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 53. 1–8. 2 indexed citations
18.
Verdaguer, Ester, Anna M. Canudas, Andrés Jiménez, et al.. (2003). Antiapoptotic effects of roscovitine in cerebellar granule cells deprived of serum and potassium: a cell cycle-related mechanism. Neurochemistry International. 44(4). 251–261. 30 indexed citations
19.
Pubill, David, Ester Verdaguer, Francesc X. Sureda, et al.. (2001). Orphenadrine prevents 3‐nitropropionic acid‐induced neurotoxicity in vitro and in vivo. British Journal of Pharmacology. 132(3). 693–702. 38 indexed citations
20.
Jiménez, Andrés, David Pubill, Mercè Pallàs, et al.. (2000). Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis. European Journal of Pharmacology. 398(1). 31–39. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026